← Leaderboards
Carl T. Wild
Panacos Pharmaceuticals, Inc.
$690,847
Attributed
$690,847
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$690,847 · 2
By mechanism
R43$690,847 · 2
Top collaborators
No co-investigators on record.
Most similar at Panacos Pharmaceuticals, Inc.
Same institution · by research overlap
- Graham P Allaway$3,192,910
- Karl Salzwedel$513,175
Others in their field
Top investigators on “Hiv Envelope Protein Gp41”
- Joseph G Sodroski · University Of Pennsylvania$28,732,973
- Sean P. J. Whelan · Washington University$19,061,505
- Bing Chen · Boston Children'S Hospital$15,548,054
- Ellis L Reinherz · Dana-Farber Cancer Institute$13,498,689
- Min Lu · Weill Medical College Of Cornell Univ$10,468,787
- Michael B Zwick · Scripps Research Institute, The$9,157,448
Research focus
Hiv Envelope Protein Gp41Laboratory RatAntiaids AgentOral AdministrationPharmacokineticsHigh Throughput TechnologyHiv InfectionsDrug Discovery /IsolationVirus ReceptorsHuman Immunodeficiency Virus 1Aids VaccinesCell LineGuinea PigsActive ImmunizationNeutralizing AntibodySynthetic VaccinesVaccine DevelopmentVirus Protein